Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Texas Instruments Stock Falls on Soft Guidance, Analysts Blame Restrictions in China

Published 2022-04-27, 09:02 a/m
Updated 2022-04-27, 09:02 a/m
© Reuters.

Texas Instruments (NASDAQ:TXN) issued a weaker-than-expected Q2 forecast, sending its shares tumbling more than 3% in premarket trading Wednesday.

The company reported Q1 revenue of $4.91 billion, up 14% YoY and above the analyst consensus of $4.72 billion. Strong sales were fueled by “growth in industrial and automotive.”

TXN reported Q2 EPS of $2.35, up from $1.87 in the year-ago period. The EPS print took into account a 2-cent benefit for items that were not included in the initial guidance.

Analog revenue stood at $3.82 billion, up 16% YoY, topping the consensus estimates of $3.67 billion. Embedded processing revenue came in at $782 million, up 2% YoY and compared to the estimated $769 million.

For Q2, the semiconductor maker expects revenue in the range of $4.2 billion to $4.8 billion, missing the consensus estimates of $4.96 billion.

TXN expects EPS in the range of $1.84 to $2.26, short of the estimated $2.28 per share.

“This outlook comprehends an impact due to reduced demand from COVID-19 restrictions in China,” the company said in a press release.

Barclays analyst Blayne Curtis lowered the price target to $150.00 per share from $170.00 and said TXN’s results should be seen as “merely the beginning of a broader cyclical correction.”

“The lower June guidance was a surprise, but we do expect increased shortages and shutdowns to be a bigger trend through earnings… We do see a substantial cycle coming and this reset as only the beginning of a larger correction. TXN history tells us that every DD growth year is usually followed by decline the year after, and after 27% growth in 2021, we view a sizable correction as needed. We do recognize that analog names are typically safer in a market correction but we still don’t believe the stock has corrected enough to become interesting,” Curtis said on the Underweight-rated TXN stock.

BofA analyst Vivek Arya lowered the price target to $190.00 per share from the prior $200.00 and is more bullish on TXN than his Barclays (LON:BARC) colleague.

“We reiterate Buy on a strong track record of consistent share gains, free cash flow generation and returns, and profitability resilience even in a downcycle,” Curtis said in a note.

By Senad Karaahmetovic

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.